Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II).
Hattori N, Nakayama G, Uehara K, Aiba T, Ishigure K, Sakamoto E, Tojima Y, Kanda M, Kobayashi D, Tanaka C, Yamada S, Koike M, Fujiwara M, Nagino M, Kodera Y.
Hattori N, et al. Among authors: aiba t.
Int J Clin Oncol. 2020 Jan;25(1):118-125. doi: 10.1007/s10147-019-01546-3. Epub 2019 Sep 21.
Int J Clin Oncol. 2020.
PMID: 31542847
Free PMC article.
Clinical Trial.